Author name: mikeco

The 43rd Graduation Ceremony of Residents took place on January 7, 2025, at the CGHMC Auditorium. Dr. Samuel Ang, Medical Director, welcomed the new graduates and their parents. He thanked the parents for allowing their children to work at the hospital despite the pandemic. The Residents were graduates from the Department of Anesthesiology, Internal Medicine, […]

Unveiling The New uCT 780 Manila, Philippines – The Chinese General Hospital and Medical Center (CGHMC) recently installed the cutting-edge uCT 780, a 160-slice computed tomography system from United Imaging Healthcare. The ribbon-cutting of the newest CT was led by (from left to right) Philmed Dynasty President Michael Chuakaw, PCCAI Vice-Chairman Mr. Alberto Tan Lee,

The Chinese General Hospital and Medical Center (CGHMC) has achieved a groundbreaking medical milestone with the successful completion of the first-ever Transhepatic Stent-Assisted Portal Vein Aneurysm Coil Embolization.

The Chinese General Hospital and Medical Center (CGHMC) recently celebrated a remarkable achievement—more than 300 robotic surgery cases completed in just two years, the fastest among hospitals in the country to reach this milestone. This accomplishment underscores the hospital’s unwavering commitment to innovation and patient care, made possible by its bold decision in 2022 to

Manila, Philippines — The Chinese General Hospital and Medical Center (CGHMC) and the Philippine Chinese Charitable Association, Inc. (PCCAI) successfully held their Media Appreciation and MOA Signing Day with major local media on December 9, 2024. The MOA will provide medical assistance through discounts on selected laboratory services and room rates to members of various

The Chinese General Hospital and Medical Center (CGHMC) is excited to introduce the Gamma Probe in its Department of Nuclear Medicine and Theranostics. This device enhances the precision of radioguided surgeries, helping doctors target and remove cancerous or problematic tissue with unmatched accuracy. For patients, this means safer procedures, faster recovery, and a focus on

The Chinese General Hospital and Medical Center (CGHMC) has recently taken significant strides in expanding access to state-of-the-art technology for patients with advanced prostate cancer. The Department of Nuclear Medicine and Theranostics, in coordination with a multispecialty team of physicians, performed its first administration of Lutetium-177 Prostate-Specific Membrane Antigen Radioligand Therapy (Lu-177 PRLT). The introduction